Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000899243-20-030329

President, CEO, and Chairman acquired 750,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sommadossi Jean-Pierre President, CEO, and Chairman 2020-11-03 Conversion +750,000 5,925,000 I
Derivatives
Sommadossi Jean-Pierre President, CEO, and Chairman 2020-11-03 Conversion · Series A Convertible Preferred Stock −750,000 0 I
Loading xslF345X03/doc4.xml…